GlassScriptPhysician profile
Cheryl D Short
NPI 1790846517
$2,908.86
in general payments reported to CMS, 2019-2025
32 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $596 · 2020: $258 · 2021: $646 · 2022: $404 · 2023: $422 · 2024: $269 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,005.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,161.18 | 2019-2025 | Lo Loestrin Fe, Liletta, Orilissa |
| Astellas Pharma US INC | $359.47 | 2019-2025 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $238.29 | 2019-2025 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $112.12 | 2019-2020 | |
| Therapeuticsmd, INC. | $103.57 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $96.21 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $86.71 | 2020-2025 | Slynd |
| Pfizer INC. | $72.39 | 2019-2024 | |
| Agile Therapeutics, INC. | $64.25 | 2021-2022 | |
| Hologic Sales and Service, LLC | $63.26 | 2021-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Ethicon US, LLC | $52.32 | 2025 | Vistaseal, Stratafix |
| Organon LLC | $42.69 | 2021-2024 | |
| Avion Pharmaceuticals | $36.96 | 2019-2021 | |
| Biogen, INC. | $36.26 | 2025 | Zurzuvae |
| Biohaven Pharmaceuticals, INC. | $35.03 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $30.91 | 2019 | |
| Merck Sharp & Dohme LLC | $30.69 | 2019-2021 | |
| Becton, Dickinson and Company | $28.67 | 2020 | |
| Lupin INC. | $26.96 | 2019 | |
| Myovant Sciences INC. | $25.48 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.56 | 2022 | |
| Exact Sciences Corporation | $22.86 | 2025 | The Cologuard Plus Collection Kit |
| Mylan Pharmaceuticals INC. | $22.70 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $19.31 | 2019 | |
| Boston Scientific Corporation | $18.32 | 2019 | |
| Millicent US INC | $17.70 | 2021 | |
| Evofem Biosciences, INC. | $15.99 | 2021 | |
| Hologic INC | $14.20 | 2021 | |
| Mayne Pharma Commercial LLC | $14.11 | 2023 | |
| Shield Therapeutics INC | $13.75 | 2024 | |
| Dysis Medical, INC. | $12.26 | 2021 | |
| Aspira Women'S Health INC | $10.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Short listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.